Why the study?
Cancers impose significant economic burdens, and reliable burden estimates are needed to help guide resource allocation.
What is the direct and indirect economic burden of the top ten most costly cancers compared to acute coronary syndrome in Taiwan?
Population
545 221 patients with newly diagnosed cancer and 170 879 patients with ACS in Taiwan
Comparison
Top ten most costly cancers vs ACS
Design
Population-based cohort study
Follow-up
3 years after diagnosis
Authors
Loading...
Indirect costs exceed 50% of cancer burden and surpass ACS; leaves open targeted mitigation strategies pending prospective data.
What is the direct and indirect economic burden of the top ten most costly cancers compared to acute coronary syndrome in Taiwan?
This nationwide study demonstrates the substantial economic burden of the top 10 most costly cancers in Taiwan, highlighting that indirect costs account for over 50% of the total burden for most cancers and that cancer costs generally exceed those of acute coronary syndrome.
Huang et al. (2020) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: